Kenneth M. Verburg - Clin Dev & Operat Business Unit, Pfizer Inc

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 69 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Predicting Treatment Responses in Patients with Osteoarthritis: Results from Two Phase III Tanezumab Randomized Clinical Trials

Luana Colloca,Robert H. Dworkin,John T. Farrar,Leslie Tive, Jiyue Yang,Lars Viktrup,Gorana Dasic,Christine R. West,Ed Whalen,Mark T. Brown,Steven A. Gilbert,Kenneth M. Verburg

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 4 (2023): 878-886

引用1浏览0WOS引用

Characterization of Adverse Joint Outcomes in Patients with Osteoarthritis Treated with Subcutaneous Tanezumab

John A. Carrino,Timothy E. McAlindon, Tom J. Schnitzer,Ali Guermazi,Marc C. Hochberg,Philip G. Conaghan,Mark T. Brown,Aimee Burr,Robert J. Fountaine,Glenn C. Pixton,Lars Viktrup,Kenneth M. Verburg,Christine R. West

Osteoarthritis and Cartilageno. 12 (2023): 1612-1626

引用0浏览0WOS引用

Observed Efficacy and Clinically Important Improvements in Participants with Osteoarthritis Treated with Subcutaneous Tanezumab: Results from a 56-Week Randomized NSAID-controlled Study

Neogi Tuhina,Hunter David J.,Churchill Melvin,Shirinsky Ivan,White Alexander,Guermazi Ali,Omata Masanari,Fountaine Robert J.,Pixton Glenn,Viktrup Lars,Brown Mark T.,West Christine R.,Verburg Kenneth M.

Arthritis Research & Therapy（2022）

引用1浏览0WOS引用

Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis from a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial

John D. Markman,Thomas J. Schnitzer,Serge Perrot,Said R. Beydoun,Seiji Ohtori,Lars Viktrup,Ruoyong Yang,Candace Bramson,Christine R. West,Kenneth M. Verburg

Pain and Therapy（2022）

引用2浏览0WOS引用

Neurological Safety of Subcutaneous Tanezumab Versus NSAID in Patients with Osteoarthritis

Mark T. Brown,Paola Sandroni,Phillip A. Low,Kenneth C. Gorson,David J. Hunter,Glenn C. Pixton,Robert J. Fountaine,Lars Viktrup,Christine R. West,Kenneth M. Verburg

Journal of the Neurological Sciences（2022）

引用3浏览0WOS引用

Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial

Marc C. Hochberg,John A. Carrino,Thomas J. Schnitzer,Ali Guermazi,David A. Walsh,Alexander White,Satoru Nakajo,Robert J. Fountaine,Anne Hickman,Glenn Pixton,Lars Viktrup,Mark T. Brown,Christine R. West,Kenneth M. Verburg

ARTHRITIS & RHEUMATOLOGYno. 7 (2021): 1167-1177

引用35浏览0WOS引用

Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study

Shin-Ichi Konno,Takuya Nikaido,John D. Markman,Makoto Ohta, Toshiya Machida,Naoki Isogawa,Hiroki Yoshimatsu,Lars Viktrup,Mark T. Brown,Christine R. West,Kenneth M. Verburg

PAIN MANAGEMENT（2021）

引用2浏览0WOS引用

Joint Safety of Tanezumab versus NSAIDs; A Combined Assessment of Benefit and Harm

Robert Fountaine,Robert Dworkin,Anne Hickman,Glenn Pixton,Ed Whalen,Christine West,Kenneth Verburg

ARTHRITIS & RHEUMATOLOGY（2021）

引用0浏览0引用

Dose (Exposure) Efficacy Response of Tanezumab Following Intravenous and Subcutaneous Administration Across Phase 2 and Phase 3 Studies in Patients with Osteoarthritis of Hip and Knee

Martin Boucher,Kenneth Verburg,Puneet Gaitonde,Scott Marshall

ARTHRITIS & RHEUMATOLOGY（2021）

引用0浏览0引用

Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis

Schnitzer, Thomas J.,Berenbaum, Francis,Conaghan, Philip G.,Dworkin, Robert H.,Gatti, Davide,Yang, Ruoyong,Viktrup, Lars,Davignon, Isabelle,West, Christine R.,Verburg, Kenneth M.

Rheumatology and Therapy（2021）

引用4浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn